Literature DB >> 8021493

Phenotypic characterization of CD4-/alpha beta TCR+ and gamma delta TCR+ T cells with a transendothelial migratory capacity.

P Galéa1, R Brezinschek, P E Lipsky, N Oppenheimer-Marks.   

Abstract

During inflammation, both CD4+ and CD4- T lymphocytes extravasate into perivascular tissues by adhering to and migrating through the vascular endothelium. These studies were undertaken to characterize the phenotype of CD4- T cells that have a capacity to migrate through endothelium. Results show that CD4- T cells exhibit a greater capacity to migrate through endothelial cells (EC) than CD4+ T cells; and that TCR-gamma delta+ T cells exhibited the greatest migratory capacity. The migrating CD8+ T cell population was enriched in CD45RO+/L-selectin-/LFA-1bright/CD29bright/CD 44bright cells. TNF-alpha-activated EC did not support increased CD4- T cell transendothelial migration and changes in the phenotype of the migrating CD8+ T cells. The migrating CD4- T cell population was enriched in VLA-2+ T cells and expressed increased densities of VLA-4, VLA-5, and VLA-6. The migrating TCR-gamma delta+ T cell population contained both CD8dim and CD8- T cells. Moreover, the migrating gamma delta T cell population was not different from the initial or nonadherent population in that it contained CD45RO+, CD45RA+, and L-selectin+ cells. Finally, migrating TCR-gamma delta+ T cells contained cells expressing V delta 2 and V gamma 9 TCR chains, but these were not enriched compared with the initial population. These studies have characterized the CD4- T cells that are capable of transendothelial migration in vitro. The results are consistent with the conclusion that unique subpopulations of CD8+ alpha beta and CD8+ and CD8- gamma delta T cells gain access to inflammatory sites by virtue of their intrinsic ability to migrate across the endothelium.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8021493

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

1.  T lymphocyte lines isolated from atheromatous plaque contain cells capable of responding to Chlamydia antigens.

Authors:  A J Curry; I Portig; J C Goodall; P J Kirkpatrick; J S Gaston
Journal:  Clin Exp Immunol       Date:  2000-08       Impact factor: 4.330

2.  Selective migration of highly differentiated primed T cells, defined by low expression of CD45RB, across human umbilical vein endothelial cells: effects of viral infection on transmigration.

Authors:  N J Borthwick; A N Akbar; L P MacCormac; M Lowdell; J L Craigen; I Hassan; J E Grundy; M Salmon; K L Yong
Journal:  Immunology       Date:  1997-02       Impact factor: 7.397

Review 3.  Adhesion molecules in rheumatoid arthritis.

Authors:  N Oppenheimer-Marks; P E Lipsky
Journal:  Springer Semin Immunopathol       Date:  1998

Review 4.  gamma/delta and other unconventional T lymphocytes: what do they see and what do they do?

Authors:  S H Kaufmann
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-19       Impact factor: 11.205

Review 5.  Recognition of nonpeptide antigens by T cells.

Authors:  Y Tanaka; M B Brenner; B R Bloom; C T Morita
Journal:  J Mol Med (Berl)       Date:  1996-05       Impact factor: 4.599

6.  Changes in human mucosal gamma delta T cell repertoire and function associated with the disease process in inflammatory bowel disease.

Authors:  L D McVay; B Li; R Biancaniello; M A Creighton; D Bachwich; G Lichtenstein; J L Rombeau; S R Carding
Journal:  Mol Med       Date:  1997-03       Impact factor: 6.354

7.  Increased transendothelial migration of scleroderma lymphocytes.

Authors:  G H Stummvoll; M Aringer; J Grisar; C W Steiner; J S Smolen; R Knobler; W B Graninger
Journal:  Ann Rheum Dis       Date:  2004-05       Impact factor: 19.103

Review 8.  gammadelta T cells: the overlooked T-cell subset in demyelinating disease.

Authors:  Jillian E Wohler; Sherry S Smith; Scott R Barnum
Journal:  J Neurosci Res       Date:  2010-01       Impact factor: 4.164

9.  Gammadelta T cells in EAE: early trafficking events and cytokine requirements.

Authors:  Jillian E Wohler; Sherry S Smith; Kurt R Zinn; Dan C Bullard; Scott R Barnum
Journal:  Eur J Immunol       Date:  2009-06       Impact factor: 5.532

10.  Analysis of T cell subsets present in the peripheral blood and synovial fluid of reactive arthritis patients.

Authors:  H Beacock-Sharp; J L Young; J S Gaston
Journal:  Ann Rheum Dis       Date:  1998-02       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.